X
The life sciences industry is embracing a more strategic, targeted approach to mergers and acquisitions (M&A). Gone are the days of large, high-profile deals; instead, companies are focusing on acquiring specific capabilities and technologies that enhance their core operations.
This podcast, based on a GEP bulletin, says the new approach to M&A isn’t just about innovation—it’s about resilience. Companies are leveraging acquisitions to strengthen their supply chains, mitigate inflationary pressures, and streamline operations.
What You'll Hear:
- How AI and innovation strengthen supply chains and mitigate risks in life sciences M&As
- Why ESG priorities are shaping modern M&A decisions
- Strategies for seamless team integration and cultural alignment